Literature DB >> 26969673

Usefulness of Preoperative Plasma Fibrinogen Versus Other Prognostic Markers for Predicting Gastric Cancer Recurrence.

Masaaki Yamamoto1, Yukinori Kurokawa2, Yasuhiro Miyazaki1, Tomoki Makino1, Tsuyoshi Takahashi1, Makoto Yamasaki1, Kiyokazu Nakajima1, Shuji Takiguchi1, Masaki Mori1, Yuichiro Doki1.   

Abstract

BACKGROUND: Hypercoagulation is associated with tumor progression and metastasis in various types of malignancy. We compared the prognostic value of preoperative plasma fibrinogen level with those of other prognostic markers in patients with gastric cancer and assessed whether fibrinogen level was an independent prognostic indicator.
METHODS: We collected preoperative data from 609 consecutive patients with gastric cancer who underwent curative gastrectomy. A receiver operating curve (ROC) was used to compare the sensitivity and specificity of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), C-reactive protein (CRP), platelet count, platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), and fibrinogen level in predicting recurrence. Recurrence-free survival (RFS) and overall survival (OS) were compared between the normal and high fibrinogen groups.
RESULTS: In the ROC analysis, the area under the curve (AUC) was 0.534 for CEA, 0.552 for CA19-9, 0.587 for CRP, 0.565 for platelet count, 0.567 for PLR, 0.522 for NLR, and 0.692 for fibrinogen. Plasma fibrinogen level increased with tumor stage. The high fibrinogen (≥350 mg/dl) group had significantly worse RFS (p < 0.001) and OS (p < 0.001) than the normal fibrinogen (<350 mg/dl) group. Cox multivariate analysis of RFS revealed that fibrinogen level was an independent prognostic factor (p < 0.001) in addition to sex, pT stage, and pN stage.
CONCLUSIONS: Preoperative plasma fibrinogen level had the highest predictive value for recurrence among seven known prognostic markers. Since fibrinogen level is an independent factor for RFS, it would be useful for predicting prognosis after gastric cancer surgery.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26969673     DOI: 10.1007/s00268-016-3474-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  23 in total

Review 1.  Neoadjuvant chemotherapy for gastric cancer in Japan: a standing position by comparing with adjuvant chemotherapy.

Authors:  Takaki Yoshikawa; Yasushi Rino; Norio Yukawa; Takashi Oshima; Akira Tsuburaya; Munetaka Masuda
Journal:  Surg Today       Date:  2013-03-19       Impact factor: 2.549

2.  Hyperfibrinogenemia is a useful predictor for lymphatic metastasis in human gastric cancer.

Authors:  Hiroharu Yamashita; Joji Kitayama; Hirokazu Nagawa
Journal:  Jpn J Clin Oncol       Date:  2005-09-26       Impact factor: 3.019

3.  Hemostatic alterations in patients with benign and malignant colorectal disease during major abdominal surgery.

Authors:  I I Modrau; L L Iversen; O O Thorlacius-Ussing
Journal:  Thromb Res       Date:  2001-12-01       Impact factor: 3.944

Review 4.  Thrombosis and cancer.

Authors:  H F Dvorak
Journal:  Hum Pathol       Date:  1987-03       Impact factor: 3.466

5.  Pathogenesis of ascites tumor growth: fibrinogen influx and fibrin accumulation in tissues lining the peritoneal cavity.

Authors:  J A Nagy; M S Meyers; E M Masse; K T Herzberg; H F Dvorak
Journal:  Cancer Res       Date:  1995-01-15       Impact factor: 12.701

6.  Prognostic value of preoperative serum tumor markers in gastric cancer.

Authors:  Ze-Bo Huang; Xin Zhou; Jun Xu; Yi-Ping Du; Wei Zhu; Jian Wang; Yong-Qian Shu; Ping Liu
Journal:  World J Clin Oncol       Date:  2014-05-10

7.  Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody.

Authors:  J S Bennett; J A Hoxie; S F Leitman; G Vilaire; D B Cines
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer.

Authors:  Do-Kyong Kim; Sung Yong Oh; Hyuk-Chan Kwon; Suee Lee; Kyung A Kwon; Byung Geun Kim; Seong-Geun Kim; Sung-Hyun Kim; Jin Seok Jang; Min Chan Kim; Kyeong Hee Kim; Jin-Yeong Han; Hyo-Jin Kim
Journal:  BMC Cancer       Date:  2009-05-20       Impact factor: 4.430

10.  Prognostic value of PLR in various cancers: a meta-analysis.

Authors:  Xin Zhou; Yiping Du; Zebo Huang; Jun Xu; Tianzhu Qiu; Jian Wang; Tongshan Wang; Wei Zhu; Ping Liu
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

View more
  15 in total

1.  Prognostic Impact of Change in the Fibrinogen and Albumin Score During Preoperative Treatment in Esophageal Cancer Patients.

Authors:  Satoru Matsuda; Hiroya Takeuchi; Hirofumi Kawakubo; Kazumasa Fukuda; Rieko Nakamura; Koichi Suda; Norihito Wada; Yuko Kitagawa
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

2.  Prognostic Impact of Using Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Resectable Non-small Cell Lung Cancer.

Authors:  Masashi Iwasaki; Shunta Ishihara; Satoru Okada; Reona Shimegi; Masanori Shimomura; Masayoshi Inoue
Journal:  Ann Surg Oncol       Date:  2022-06-02       Impact factor: 4.339

3.  RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.

Authors:  Yikun Cheng; Bin Yang; Yanfeng Xi; Xing Chen
Journal:  Tumour Biol       Date:  2016-09-20

4.  C-reactive protein/albumin and neutrophil/lymphocyte ratios and their combination predict overall survival in patients with gastric cancer.

Authors:  Minjie Mao; Xiaoli Wei; Hui Sheng; Peidong Chi; Yijun Liu; Xiaoyan Huang; Yifan Xiang; Qianying Zhu; Shan Xing; Wanli Liu
Journal:  Oncol Lett       Date:  2017-10-13       Impact factor: 2.967

5.  Epidermal growth factor-like domain multiple 6 (EGFL6) promotes the migration and invasion of gastric cancer cells by inducing epithelial-mesenchymal transition.

Authors:  Fu-Chun Huo; Wen-Tao Zhu; Xu Liu; Yun Zhou; Lan-Sheng Zhang; Jie Mou
Journal:  Invest New Drugs       Date:  2020-09-19       Impact factor: 3.850

6.  A nomogram combining plasma fibrinogen and systemic immune‑inflammation index predicts survival in patients with resectable gastric cancer.

Authors:  Pan-Xing Wang; Hai-Jiang Wang; Jia-Huang Liu; Guang-Lin Qiu; Jing Lu; Lin Fan; Xin-Hua Liao; Xiang-Ming Che
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

7.  Using a nomogram based on preoperative serum fibrinogen levels to predict recurrence of papillary thyroid carcinoma.

Authors:  Lei Jianyong; Li Zhihui; Gong Rixiang; Zhu Jingqiang
Journal:  BMC Cancer       Date:  2018-04-05       Impact factor: 4.430

8.  A cumulative score based on preoperative fibrinogen and the neutrophil-lymphocyte ratio to predict outcomes in resectable gastric cancer.

Authors:  Xuechao Liu; Zhimin Liu; Enzi Lin; Yingbo Chen; Xiaowei Sun; Zhiwei Zhou
Journal:  Cancer Manag Res       Date:  2018-08-28       Impact factor: 3.989

9.  Clinicopathological and prognostic value of preoperative plasma fibrinogen in gastric cancer patients: A meta-analysis.

Authors:  Fei Cheng; Chunyan Zeng; Ling Zeng; Youxiang Chen
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.889

10.  Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients.

Authors:  Wei-Yu Xu; Hao-Hai Zhang; Xiao-Bo Yang; Yi Bai; Jian-Zhen Lin; Jun-Yu Long; Jian-Ping Xiong; Jun-Wei Zhang; Xin-Ting Sang; Hai-Tao Zhao
Journal:  World J Gastroenterol       Date:  2018-04-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.